Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa–carbidopa intestinal gel infusion-Reference-Cited by-同舟云学术

Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa–carbidopa intestinal gel infusion

Published:2015-08 Issue:8 Volume:21 Page:968-971
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Solla Paolo,Fasano Alfonso,Cannas Antonino,Mulas Cesare Salvatore,Marrosu Maria Giovanna,Lang Anthony E.,Marrosu Francesco

Funder

Sardinia Regional Government

European Social Fund

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference7 articles.

1. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study;Olanow;Lancet Neurol.,2014

2. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life;Fasano;Eur. Rev. Med. Pharmacol. Sci.,2012

3. Dopamine agonist withdrawal syndrome in Parkinson disease;Rabinak;Arch. Neurol.,2010

4. Characteristics of apathy in Parkinson's disease;Dujardin;Mov. Disord.,2007

5. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic;Pondal;J. Neurol. Neurosurg. Psychiatr.,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical evidence and mechanisms of traditional Chinese medicine in major diseases;Science of Traditional Chinese Medicine;2023-09

2. Wuzi Yanzong Pill Plays A Neuroprotective Role in Parkinson’s Disease Mice via Regulating Unfolded Protein Response Mediated by Endoplasmic Reticulum Stress;Chinese Journal of Integrative Medicine;2022-11-12

3. Rasagiline Withdrawal Syndrome in Parkinson’s Disease;Brain Sciences;2022-02-05

4. Tratamiento farmacológico de los síntomas motores de la enfermedad de Parkinson: actualización y recomendaciones de un experto;Revista de Neurología;2022

5. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease;npj Parkinson's Disease;2021-11-30